Literatur
- 1
Palmer D R, Perry K R, Mortimer P P. et al .
Variation in the sensitivity of HBsAg screening kits.
Transfus Med.
1996;
6 (4)
311-317 (IIb)
- 2
Weber B, Dengler T, Berger A. et al .
Evaluation of two new automated assays for hepatitis B virus surface antigen (HBsAg)
detection: Immulite HBsAg and Immulite 2000 HBsAg.
J Clin Microbiol.
2003;
41 (1)
135-143 (IIb)
- 3
Colloredo G, Bellati G, Leandro G. et al .
Quantitative analysis of IgM anti-HBc in chronic hepatitis B patients using a new
“gray-zone” for the evaluation of “borderline” values.
J Hepatol.
1996;
25 (5)
644-648 (IIa)
- 4
Colloredo M els G, Bellati G, Leandro G. et al .
Role of IgM antibody to hepatitis B core antigen in the diagnosis of hepatitis B exacerbations.
Arch Virol Suppl.
1993;
8
203-211 (Ib)
- 5 Haller O A, Mertens T. Diagnostik und Therapie von Viruskrankheiten: Leitlinien
der Gesellschaft für Virologie. 1. Auflage. München; Urban und Fischer-Verlag 1999
- 6
Gunther S, Fischer L, Pult I. et al .
Naturally occurring variants of hepatitis B virus.
Adv Virus Res.
1999;
52
25-137 (review)
- 7
Gilbert N, Corden S, Ijaz S. et al .
Comparison of commercial assays for the quantification of HBV-DNA load in health care
workers: calibration differences.
J Virol Methods.
2002;
100
37-47 (IIb)
- 8
Pawlotsky J M, Basie A, Hezode C. et al .
Routine detection and quantification of hepatitis B virus DNA in clinical laboratories:
performance of three commercial assays.
J Virol Methods.
2000;
85
11-21 (IIb)
- 9
Zöllner B, Petersen J, Schäfer P. et al .
Subtype-dependent response of hepatitis B virus during the early phase of lamivudine
treatment.
Clin Infect Dis.
2002;
34 (9)
1273-1277 (IIa)
- 10
Repp R. et al .
Genotyping by multiplex polymerase chain reaction for detection of endemic hepatitis
B virus transmission.
J Clin Microbiol.
1993;
31
1095-1102 (IIb)
- 11
Papatheodoridis G V, Dimou E, Laras A. et al .
Course of virologic breakthroughs under long-term lamivudine in HBeAg-negative precore
mutant HBV liver disease.
Hepatology.
2002;
36 (1)
219-226 (IIa)
- 12
Zöllner B, Schäfer P, Feucht H H. et al .
Correlation of hepatitis B virus load with loss of e antigen and emerging drug-resistant
variants during lamivudine therapy.
J Med Virol.
2001;
65 (4)
659-663 (IIa)
- 13
Dienstag J L.
The role of liver biopsy in chronic hepatitis C.
Hepatology.
2002;
36
152-160 (Ia)
- 14
Marcellin P, Asselah T, Boyer N.
Fibrosis and disease progression in hepatitis C.
Hepatology.
2002;
36
47-56 (Ib)
- 15
Pradat P, Poynard T, Alberti A. et al .
Predictive value of ALT levels on histological findings in chronic hepatitis C: A
European collaborative study.
J Hepatol.
2001;
24 (Suppl. 1) 5 (Ib)
- 16
Gebo K A, Herlong H F, Torbenson M S. et al .
Role of liver biopsy in management of chronic hepatitis C: a systematic review.
Hepatology.
2002;
36
161-172 (Ia)
Prof. Dr. med. Michael Roggendorf
Universitätsklinikum Essen, Direktor des Instituts für Virologie
Hufelandstr. 55
45122 Essen
Email: roggendorf@uni-essen.de
